Completed NA INTERVENTIONAL 2-arm NCT02012023

Use of One Kind of Controllable Tube Ileostomy in the Low Rectal Cancer (CTI)

Use of One Kind of Controllable Tube Ileostomy to Protect Anastomotic Leakage in the Low Rectal Cancer.

Sponsor: First Affiliated Hospital of Zhejiang University

Conditions Low Anterior Resection Rectal Neoplasms

Interventions Low anterior resection accept reversal operation loop ileostomy remove the tube ileostomy tube ileostomy

Updated 6 times since 2017 Last updated: Aug 21, 2016 Started: Jan 31, 2014 Primary completion: Aug 31, 2016 Completion: Aug 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Low Anterior Resection and Rectal Neoplasms, this trial is completed. The trial is conducted by First Affiliated Hospital of Zhejiang University and has accumulated 6 data snapshots since 2014. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jan 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

First Affiliated Hospital of Zhejiang University

Data source: First Affiliated Hospital of Zhejiang University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hangzhou, China